SG
CVRS

Societe Generale’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Societe Generale’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$83K Buy
+58,294
New +$67.6K ﹤0.01% 2414

Other funds holding CVRS

HPM
HealthCor Partners Management Charleston, South Carolina $50.7M AUM
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
GH
GAM Holding Zurich, Switzerland $1.57B AUM 25.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Societe Generale's CVRS Position: Q2 2016 in Review

Societe Generale opened a new position in CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q2 2016: 58,294 shares worth $83K. The stake represents ﹤0.01% of the portfolio and ranks #2414 among its holdings.

40 funds tracked by Wall St. Rank hold CVRS as of Q2 2016.

  • Societe Generale held 58,294 shares of CORINDUS VASCULAR ROBOTICS, INC worth $83K as of Q2 2016.
  • CORINDUS VASCULAR ROBOTICS, INC was a new Societe Generale position in Q2 2016.
  • CORINDUS VASCULAR ROBOTICS, INC made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #2414 holding.
  • 40 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.